Dayna Salasche
Chgo, ILNPI 1053377234
Payments from drug & device makers
$1,763in general payments, 2019–2025
Across 90 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$666
- Coopersurgical, Inc.$154
- Organon$124
- Hologic Sales And Service, LLC$112
- Exeltis, USA Inc.$111
- Astellas Pharma US Inc$77
- plus $519 from 14 others
What the payments were for
- Food & beverage$1,763100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $666 |
| Coopersurgical, Inc. | 9 | $154 |
| Organon | 8 | $124 |
| Hologic Sales And Service, LLC | 6 | $112 |
| Exeltis, USA Inc. | 5 | $111 |
| Astellas Pharma US Inc | 3 | $77 |
| Mayne Pharma Commercial LLC | 4 | $69 |
| Merck | 4 | $65 |
| Bayer | 3 | $65 |
| Millicent US Inc | 3 | $64 |
| Novo Nordisk | 2 | $41 |
| Channel Medsystems, Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Myovant Sciences Inc. | 1 | $28 |
| Therapeuticsmd, Inc. | 2 | $28 |
| Biogen | 1 | $26 |
| Pfizer | 1 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Lupin Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.